Alexander C. Sapir serves as the Chief Executive Officer, President, and a member of the Board of Directors of Fulcrum Therapeutics, Inc. Having assumed the executive leadership role, he brings over two decades of biopharmaceutical industry experience managing corporate transformations, clinical pipeline strategies, and commercial growth. Under his leadership, the organization has navigated complex clinical developments and strategic corporate restructuring phases to advance its therapeutics portfolio and maximize shareholder value across the biotechnology sector.